R
Richard Zeifman
Assistant Professor of Psychology and Director of PATH Lab
Key Impact
Investigates mechanisms of change in psychedelic therapy for depression, trauma, and suicidality.
Background & Research
Dr. Richard Zeifman leads the PATH Lab at The New School, focusing on the safety and efficacy of psychedelic-assisted therapy. As a licensed clinical psychologist and researcher, he conducts clinical trials and effectiveness studies to understand how psilocybin and MDMA promote psychological flexibility and long-term recovery in patients with MDD, cancer-related distress, and PTSD.
Focus Areas
Clinical PsychologyPsilocybin therapyTraumaSuicidality